Genes associated with an immunosuppressive state (ALDH2, TP53, or DHRS3) are associated with poor response, whereas genes associated with increased tumor activity (UAP1L1) are associated with a better response to treatment. This evidence concerns the gene DHRS3 and neoplasm.